Intraoperative floppy iris syndrome in a patient taking alfuzosin for benign prostatic hypertrophy [48]

Eye

Volumn 20, Issue 12, 2006, Pages 1431-1432

  Settas, G ^a   Fitt, A W ^a  

^a PETERBOROUGH DISTRICT HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALFUZOSIN; CYCLOPENTOLATE; LIDOCAINE; PHENYLEPHRINE;

AGED; CASE REPORT; HUMAN; INTRAOPERATIVE FLOPPY IRIS SYNDROME; IRIS DISEASE; LETTER; MALE; MYDRIASIS; OUTCOME ASSESSMENT; PATIENT SAFETY; PHACOEMULSIFICATION; PREOPERATIVE EVALUATION; PROSTATE HYPERTROPHY; SENILE CATARACT; SURGICAL TECHNIQUE; TREATMENT DURATION; TREATMENT PLANNING;

EID: 33845538746     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/sj.eye.6702291     Document Type: Letter

References (10)

1. Chang DF, Campbell JR. Intraoperative floppy iris syndrome associated with tamsulosin. J Cataract Refract Surg 2005; 31(4): 664-673.
2. Kenny BA, Miller AM, Williamson IJ, O'Connell J, Chalmers DH, Naylor AM. Evaluation of the pharmacological selectivity profile of alpha 1 adrenoceptor antagonists at prostatic alpha 1 adrenoceptors: Binding, functional and in vivo studies. Br J Pharmacol 1996; 118(4): 871-878.
3. Michel MC, Grubbel B, Taguchi K, Verfurth F, Otto T, Kropfl D. Drugs for treatment of benign prostatic hyperplasia: Affinity comparison at cloned alpha 1-adrenoceptor subtypes and in human prostate. J Auton Pharmacol 1996; 16(1): 21-28.
4. Faure C, Pimoule C, Vallancien G, Langer SZ, Graham D. Identification of alpha 1-adrenoceptor subtypes present in the human prostate. Life Sci 1994; 54(21): 1595-1605.
5. Lowe FC. Role of the newer alpha, -adrenergic-receptor antagonists in the treatment of benign prostatic hyperplasiarelated lower urinary tract symptoms. Clin Ther 2004; 26(11): 1701-1713.
6. Forray C, Noble SA. Subtype selective alpha1-adrenoceptor antagonists for the treatment of benign prostatic hyperplasia. Expert Opin Invest Drugs 1999; 8(12): 2073-2094.
7. Martin DJ. Preclinical pharmacology of alpha1-adrenoceptor antagonists. Eur Urol 1999; 36(Suppl 1): 35-41 (discussion 65).
8. Buzelin JM, Fonteyne E, Kontturi M, Witjes WP, Khan A. Comparison of tamsulosin with alfuzosin in the treatment of patients with lower urinary tract symptoms suggestive of bladder outlet obstruction (symptomatic benign prostatic hyperplasia). The European Tamsulosin Study Group. Br J Urol 1997; 80(4): 597-605.
9. Martin DJ, Lluel P, Guillot E, Coste A, Jammes D, Angel I. Comparative alpha-1 adrenoceptor subtype selectivity and functional uroselectivity of alpha-1 adrenoceptor antagonists. J Pharmacol Exp Ther 1997; 282(1): 228-235.
10. Oetting TA, Omphroy LC. Modified technique using flexible iris retractors in clear corneal surgery. J Cataract Refract Surg 2002; 28: 596-598.